Researchers develop versatile and low-cost technology for targeted long-read RNA sequencing

Inhalation drug prevents severe pneumonia: Sugar molecule accurately delivers RNA drug to target cells

Scientists have developed a CRISPR-Cas13 gene editing therapy against the RNA virus that causes hand, foot, and mouth disease, eliminating the virus in mouse models. The EV-A71 virus in severe cases can lead to nervous system disease and death.

Researchers develop 'in vivo' RNA-based gene editing model for blood disorders